NF-κB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downragulation of inducible nitric oxide synthase

British Journal of Cancer

Volumn 88, Issue 1, 2003, Pages 120-124

  De Ridder, M ^a   Van Den Berge, D L ^a   Verovski, V N ^a   Monsaert, C ^a   Wauters, N ^a   Storme, G A ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Hypoxia; iNOS; Lactacystin; NF B; Radiosensitivity

Indexed keywords

ARSENOSOBENZENE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; LACTACYSTIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PROTEASOME INHIBITOR; ACETYLCYSTEINE; ANTIINFECTIVE AGENT; CYSTEINE PROTEINASE; DRUG DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTAM; MULTIENZYME COMPLEX; NOS2 PROTEIN, MOUSE; ORGANOARSENIC DERIVATIVE; OXYGEN; PROTEASOME;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIVITY; TUMOR CELL; ANIMAL; CELL CULTURE; CELL HYPOXIA; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; RADIATION DOSE;

ACETYLCYSTEINE; ANIMALS; ANTI-BACTERIAL AGENTS; ARSENICALS; CELL HYPOXIA; CYSTEINE ENDOPEPTIDASES; DOWN-REGULATION; LACTAMS; MICE; MULTIENZYME COMPLEXES; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; PROTEASOME ENDOPEPTIDASE COMPLEX; RADIATION TOLERANCE; TUMOR CELLS, CULTURED;

EID: 0037433862     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600678     Document Type: Article

References (30)

1. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 58: 334-341
2. Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Havard L, Merville MP, Bours V (1999) Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol 19: 1950-1960
3. Bradbury CM, Markovina S, Wei SJ, Rene LM, Zoberi I, Horikoshi N, Gius D (2001) Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase. Cancer Res 61: 7689-7696
4. Dachs GU, Stratford IJ (1996) The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br J Cancer 74(Suppl XXVII): S126-S132
5. Elliott PJ, Ross JS (2001) The proteasome: a new target for novel drug therapies. Am J Clin Pathol 116: 637-646
6. Janssens MY, Van den Berge DL, Verovski VN, Monsaert C, Storme GA (1998) Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells. Cancer Res 58: 5646-5648
7. Janssens MY, Verovski VN, Van den Berge DL, Monsaert C, Storme GA (1999) Radiosensitizafion of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation. Br J Cancer 79: 1085-1089
8. Jung M, Zhang Y, Lee S, Dritschilo A (1995) Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκB-αα. Science 268: 1619-1621
9. Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310
10. Koong AC, Chen EY, Giaccia AJ (1994) Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 54: 1425-1430
11. Marshall HE, Stamler JS (2001) Inhibition of NF-κ B by S-nitrosylation. Biochemistry 40: 1688-1693
12. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182: 1683-1693
13. Melillo G, Taylor LS, Brooks A, Cox GW, Varesio L (1996) Regulation of inducible nitric oxide synthase expression in IFN-gamma-treated murine macrophages cultured under hypoxic conditions. J Immunol 157: 2638-2644
14. Mitchell JB, Wink DA, DeGraff W, Gamson J, Keefer LK, Krishna MC (1993) Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res 53: 5845-5848.
15. Miyakoshi J, Yagi K (2000) Inhibition of I κB-alpha phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells. Br J Cancer 82: 28-33
16. Musial A, Eissa NT (2001) Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J Biol Chem 276: 24268-24273
17. Oda M, Sakitani K, Kaibori M, Inoue T, Kamiyama Y, Okumura T (2000) Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes. J Biol Chem 275: 4369-4373
18. Pajonk F, Pajonk K, McBride WH (2000) Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition. Int J Radiat Oncol Biol Phys 47: 1025-1032
19. Palmer LA, Gaston B, Johns RA (2000) Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol Pharmacol 58: 1197-1203
20. Plaisance S, Vanden Berghe W, Boone E, Fiers W, Haegeman G (1997) Recombination signal sequence binding protein Jκ is constitutively bound to the NF-κB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol 17: 3733-3743
21. Royds JA, Dower SK, Qwarnstrom EE, Lewis CE (1998) Response of tumour cells to hypoxia: role of p53 and NFkB. Mol Pathol 51: 55-61
22. Russo SM, Tepper JE, Baldwin Jr AS, Liu R, Adams J, Elliott P, Cusack Jr JC (2001) Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys 50: 183-193
23. Salceda S, Caro J (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin - proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J BIOL Chem 272: 22642-22647
24. Sandau KB, Zhou J, Kietzmann T, Brune B (2001) Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferrioxamine and phenylarsine oxide. J Biol Chem 276: 39805-39811
25. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S (1995) Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44
26. Toomey D, Condron C, Wu QD, Kay E, Harmey J, Broe P, Kelly C, Bouchier-Hayes D (2001) TGF-beta1 is elevated in breast cancer tissue and regulates nitric oxide production from a number of cellular sources during hypoxia re-oxygenation injury. Br J Biomed Sci 58: 177-183
27. Van den Berge DL, De Ridder M, Verovski VN, Janssens MY, Monsaert C, Storme GA (2001) Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase. Br J Cancer 84: 1122-1125
28. Verovski VN, Van den Berge DL, Soete GA, Bols BL, Storme GA (1996) Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside. Br J Cancer 74: 1734-1742
29. Wang CY, Mayo MW, Baldwin Jr AS (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784-787
30. Xie QW, Whisnant R, Nathan C (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177: 1779-1784